FDA Approved: ZOLINZA — Supplemental Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

The FDA approved a supplemental application for Zolinza (vorinostat) filed by Merck. The action updates the labeling and may reflect changes to indications, dos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides

Drugs mentioned

• Zolinza (vorinostat)

Snippet

SUPPL AP for ZOLINZA (VORINOSTAT)